{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:26:04Z","timestamp":1791127564006,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mib.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T04:00:53Z","timestamp":1338350453000},"page":"292-299","source":"Crossref","is-referenced-by-count":21,"title":["Learning from the past: historical aspects of bacterial toxins as pharmaceuticals"],"prefix":"10.1016","volume":"15","author":[{"given":"Sabine","family":"Pellett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2012.05.005_bib0005","first-page":"1","article-title":"Vergiftung durch verdorbene W\u00fcrste","volume":"3","author":"Kerner","year":"1817","journal-title":"T\u00fcbinger Bl\u00e4tter f\u00fcr Naturwissenschaften und Arzneykunde"},{"key":"10.1016\/j.mib.2012.05.005_bib0010","series-title":"Neue Beobachtungen \u00dcber Die in W\u00fcrtemberg so H\u00e4ufig Vorfallenden T\u00f6dtlichen Vergiftungen Durch Den Genu\u00df Ger\u00e4ucherter W\u00fcrste","author":"Kerner","year":"1820"},{"key":"10.1016\/j.mib.2012.05.005_bib0015_1","article-title":"Das Fettgift Oder Die Fetts\u00e4ure Und Ihre Wirkungen Auf Den Thierischen Organismus, Ein Beytrag Zur Untersuchung Des in Verdorbenen W\u00fcrsten Giftig Wirkenden Stoffes","author":"Kerner","year":"1822","journal-title":"Cotta"},{"key":"10.1016\/j.mib.2012.05.005_bib0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0029-1220394","article-title":"Justinus Kerner's heroic experiments with botulinum toxin","volume":"36","author":"H\u00e4fner","year":"2009","journal-title":"Akt Neurol"},{"key":"10.1016\/j.mib.2012.05.005_bib0025","first-page":"365","article-title":"Das Wurstgift","volume":"40","author":"M\u00fcller","year":"1869","journal-title":"Deutsche Klinik"},{"key":"10.1016\/j.mib.2012.05.005_bib0030_1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/clinids\/1.4.701","article-title":"Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism","volume":"1","author":"van Ermengem","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.mib.2012.05.005_bib0035_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02220526","article-title":"Ueber einen neuen ana\u00ebroben Bacillus und seine Beziehungen zum Botulismus","author":"Ermengem","year":"1897","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1016\/j.mib.2012.05.005_bib0040","article-title":"Notes on Bacillus botulinus","volume":"4","author":"Burke","year":"1919","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.005_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JB.4.5.541-553.1919","article-title":"The occurrence of Bacillus botulinus in nature","volume":"4","author":"Burke","year":"1919","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.005_bib0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/43.2.152","article-title":"Studies on botulinus toxin: 3. Acid precipitation of botulinus toxin","volume":"43","author":"Snipe","year":"1928","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.05.005_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JB.52.1.1-13.1946","article-title":"Botulinum toxin (Type A); including a study of shaking with chloroform as a step in the isolation procedure","volume":"52","author":"Lamanna","year":"1946","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.005_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction","volume":"109","author":"Burgen","year":"1949","journal-title":"J Physiol"},{"key":"10.1016\/j.mib.2012.05.005_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3181\/00379727-89-21780","article-title":"Effects of salts and colloids on potency of botulinum toxin","volume":"89","author":"Boor","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.mib.2012.05.005_bib0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-9258(17)35027-5","article-title":"The elemental and amino acid composition of crystalline Clostridium botulinum type A toxin","volume":"169","author":"Buehler","year":"1947","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.005_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/IAI.1.4.423-424.1970","article-title":"Dependence of time to death on molecular size of botulinum toxin","volume":"1","author":"Lamanna","year":"1970","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.05.005_bib0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1348-0421.1967.tb00361.x","article-title":"Some chemical and physical properties of Clostridium botulinum toxins in culture","volume":"11","author":"Schantz","year":"1967","journal-title":"Jpn J Microbiol"},{"key":"10.1016\/j.mib.2012.05.005_bib0085","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/S0021-9258(18)64495-3","article-title":"Observations on the fluorescence and toxicity of botulinum toxin","volume":"235","author":"Schantz","year":"1960","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.005_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JB.94.1.277-278.1967","article-title":"Amino acid composition of crystalline botulinum toxin, type A","volume":"94","author":"Stefanye","year":"1967","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2012.05.005_bib0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0003-9861(57)90362-4","article-title":"Photooxidation of crystalline Clostridium botulinum type A toxin in the presence of methylene blue","volume":"68","author":"Weil","year":"1957","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.mib.2012.05.005_bib0100","series-title":"Neuropoisons. Their Physiological Actions","first-page":"325","article-title":"Botulinum toxin as a tool for research on the nervous system","author":"Drachman","year":"1971"},{"key":"10.1016\/j.mib.2012.05.005_bib0105","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.mib.2012.05.005_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"17","author":"Scott","year":"1980","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.mib.2012.05.005_bib0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cps.2011.03.010","article-title":"An overview of botulinum toxins: past, present, and future","volume":"38","author":"Cartee","year":"2011","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.mib.2012.05.005_bib0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1358\/dot.2010.46.9.1524356","article-title":"Botulinum toxin type A: exploring new indications","volume":"46","author":"Brashear","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.mib.2012.05.005_bib0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0065-2911(09)05503-9","article-title":"Biology and genomic analysis of Clostridium botulinum","volume":"55","author":"Peck","year":"2009","journal-title":"Adv Microb Physiol"},{"key":"10.1016\/j.mib.2012.05.005_bib0130","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","article-title":"Chapter 11 Botulism","author":"Johnson","year":"2008"},{"key":"10.1016\/j.mib.2012.05.005_bib0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.mib.2012.05.005_bib0140_1","doi-asserted-by":"crossref","first-page":"e19126","DOI":"10.1371\/journal.pone.0019126","article-title":"Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.05.005_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1213\/ANE.0b013e3181ffa1d7","article-title":"Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice","volume":"112","author":"Lee","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.mib.2012.05.005_bib0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2010.08.067","article-title":"Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models","volume":"171","author":"Marinelli","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.mib.2012.05.005_bib0155_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/toxins3010063","article-title":"Towards new uses of botulinum toxin as a novel therapeutic tool","volume":"3","author":"Pickett","year":"2011","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.mib.2012.05.005_bib0160_1","doi-asserted-by":"crossref","first-page":"10419","DOI":"10.1021\/bi201490t","article-title":"Retargeted clostridial neurotoxins as novel agents for treating chronic diseases","volume":"50","author":"Yeh","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.mib.2012.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biochi.2010.03.005","article-title":"Clostridial neurotoxins as a drug delivery vehicle targeting nervous system","volume":"92","author":"Singh","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.mib.2012.05.005_bib0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4161\/bbug.1.3.10903","article-title":"Microbial-based therapy of cancer: current progress and future prospects","volume":"1","author":"Bernardes","year":"2010","journal-title":"Bioeng Bugs"},{"key":"10.1016\/j.mib.2012.05.005_bib0175","first-page":"228","article-title":"Natural toxins and their therapeutic potential","volume":"48","author":"Kapoor","year":"2010","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.mib.2012.05.005_bib0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/17425247.2011.566269","article-title":"Human toxin-based recombinant immunotoxins\/chimeric proteins as a drug delivery system for targeted treatment of human diseases","volume":"8","author":"Lorberboum-Galski","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.mib.2012.05.005_bib0185","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1021\/ja111110e","article-title":"Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection","volume":"133","author":"Pornpattananangkul","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mib.2012.05.005_bib0190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.str.2010.12.013","article-title":"Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin","volume":"19","author":"Smith","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.mib.2012.05.005_bib0195","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1158\/1078-0432.CCR-10-2887","article-title":"HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors","volume":"17","author":"Zielinski","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mib.2012.05.005_bib0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/21548331.1997.11443597","article-title":"Thrombolytic therapy for stroke: the new paradigm","volume":"32","author":"Levine","year":"1997","journal-title":"Hosp Pract (Minneap)"},{"issue":"Suppl F","key":"10.1016\/j.mib.2012.05.005_bib0205","doi-asserted-by":"crossref","first-page":"F28","DOI":"10.1093\/eurheartj\/18.suppl_F.28","article-title":"Targeting new thrombolytic regimens at specific patient groups: implications for research and cost-containment","volume":"18","author":"Maseri","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mib.2012.05.005_bib0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/NDT.S17923","article-title":"Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine","volume":"8","author":"Robertson","year":"2012","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.mib.2012.05.005_bib0215","first-page":"1006","article-title":"Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity","volume":"7","author":"Alexiades-Armenakas","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.mib.2012.05.005_bib0220","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.mib.2012.05.005_bib0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.mib.2012.05.005_bib0230","doi-asserted-by":"crossref","first-page":"e29803","DOI":"10.1371\/journal.pone.0029803","article-title":"Central action of peripherally applied botulinum toxin type a on pain and dural protein extravasation in rat model of trigeminal neuropathy","volume":"7","author":"Filipovic","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.05.005_bib0235_1","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.mib.2012.05.005_bib0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/jphs.11121FP","article-title":"Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxin-treated foreleg of rats","volume":"117","author":"Torii","year":"2011","journal-title":"J Pharmacol Sci"},{"issue":"Suppl. 8","key":"10.1016\/j.mib.2012.05.005_bib0245","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in humans","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.mib.2012.05.005_bib0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection: type B compared with type A","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.mib.2012.05.005_bib0255","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","article-title":"Recovery from botulinum neurotoxin poisoning in vivo","volume":"139","author":"Keller","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.mib.2012.05.005_bib0260","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mib.2012.05.005_bib0265","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/01.wnl.0000187127.92446.4c","article-title":"Adult botulism type F in the United States, 1981\u20132002","volume":"65","author":"Gupta","year":"2005","journal-title":"Neurology"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T12:44:52Z","timestamp":1642337092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527412000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1369527412000598"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2012.05.005","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}